The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global patient centric healthcare app market size reached US$ 8.62 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 30.89 Billion by 2027, exhibiting a growth rate (CAGR) of 21.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A patient centric healthcare application (app) offers health-related services conveniently from a device, such as a smartphone and tablet. It is utilized by patients to monitor numerous aspects of their health, including weight, calorie count, blood glucose measurements, dehydration levels, and physical activity. It aids in managing chronic diseases like diabetes and hypertension and facilitating electronic data interchange (EDI) with clinicians. At present, there is a significant rise in the utilization of telehealth/telemedicine on account of the coronavirus disease (COVID-19) outbreak. As a result, the demand for patient centric healthcare app is rising across the globe.
Nowadays, mobile app developers are collaborating with healthcare experts to offer patient centric healthcare apps, which can work without an internet connection to support uninterrupted access. This, in confluence with the increasing reliance on smartphones and other devices for disease monitoring, represents one of the key factors driving the market. Moreover, patient centric healthcare apps help in addressing smoking cessation and keeping track of nutritional intake and vaccinations. They also enable practitioners ensure that treatments recognize the needs and preferences of a patient. As a result, these apps are increasingly being used by individuals with cancer to log medications, track treatment progress, monitor side effects, and schedule follow-up appointments. Besides this, advances in information technology (IT) have introduced new design approaches that comprise healthcare delivery and patient education. This, coupled with the increasing adoption of wearable devices, which help monitor heart rate, tremors, posture control, and sleep patterns, is offering lucrative growth opportunities to market players. Other factors, such as the increasing geriatric population and the rising health consciousness among individuals, are driving the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global patient centric healthcare app market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technology, operating system, application and end user.
Breakup by Technology:
Breakup by Operating System:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., Athenahealth Inc., Bayer Aktiengesellschaft, Boston Scientific Corporation, Hill-Rom Services Inc. (Baxter International Inc.), iPatientCare LLC, Koninklijke Philips N.V., Merck & Co. Inc., Mobilesmith Inc., Pfizer Inc. and Siemens Healthineers AG (Siemens AG).
|Base Year of the Analysis||2021|
|Segment Coverage||Technology, Operating System, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Allscripts Healthcare Solutions Inc., Athenahealth Inc., Bayer Aktiengesellschaft, Boston Scientific Corporation, Hill-Rom Services Inc. (Baxter International Inc.), iPatientCare LLC, Koninklijke Philips N.V., Merck & Co. Inc., Mobilesmith Inc., Pfizer Inc. and Siemens Healthineers AG (Siemens AG).|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at